동화약품

000020KOSPI

55.9 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40

News Sentiment18.4 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly up 2.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dongwha Pharm operates in pharmaceuticals, medical device manufacturing and sales, and other financial services. In 2023, sales increased by 6.78% to 496,394 million won compared to the previous year, but operating profit fell by 98.09%. Key subsidiaries include Medissei (medical device manufacturer), TS Care (Vietnam-based pharmaceutical distribution chain), and Dongwha Kripton (venture investment firm).

Number of Employees

838people

Average Salary

71.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

37.95Industry Average 15.000.0Point

2.5x industry avg (risky)

PBR

0.36Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

0.96Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

9.44Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼63.3% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 2.9% (declining, 3yr)

Detailed News Sentiment

20 totalPositive 15Neutral 5Negative 0Average Sentiment Score 73.5

Positive
"미국에서는 음료수입니다만"?활명수가 변신하는 이유는?
동화약품의 '활명수'가 미국 시장 진출을 통해 새로운 제품 변형 '까스활'을 출시하며 글로벌 확장에 긍정적 영향을 미칠 것으로 보입니다.
Neutral
화장품 전문기업 아마란스, 부산시 유공 표창
아마란스가 부산에서의 산업 성장과 해외 수출 기여로 표창을 받았으나, 직접적인 영향은 동화약품과 관련이 없다.
Positive
정체된 내수 시장에 해외로 눈 돌려…K건기식, 완제품·원료 ‘쌍끌이.....
동화약품 등 국내 건강기능식품 기업들이 해외 시장 확대를 통해 내수 침체를 극복하려는 전략이 긍정적으로 평가됩니다.

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 5,220Won52-week high 6,67052-week low 4,550

1-month return4.0Point

1m +2.55% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral[기재정정]반기보고서 (2026.06)2026-08-14
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식등의대량보유상황보고서(일반)2026-08-11